Low blood pressure and the risk of dementia in very old individuals.

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86

Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13

The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology (2011) 2.01

Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology (2009) 1.78

Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol (2012) 1.57

Mediterranean diet and late-life cognitive impairment: a taste of benefit. JAMA (2009) 1.55

Slaying dementia dragons with blood, lungs, and guts. J Am Geriatr Soc (2013) 1.39

Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiol Aging (2011) 1.27

Association of low blood pressure with anxiety and depression: the Nord-Trøndelag Health Study. J Epidemiol Community Health (2007) 1.25

Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22

Inflammatory markers and gait speed decline in older adults. J Gerontol A Biol Sci Med Sci (2011) 1.18

C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects. Age Ageing (2009) 1.18

Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (2012) 1.15

Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology (2009) 1.12

Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord (2010) 1.09

Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev (2009) 1.09

When being thin is not a virtue. J Am Geriatr Soc (2008) 1.07

Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat (2008) 1.03

Autoimmune autonomic ganglionopathy with reversible cognitive impairment. Arch Neurol (2011) 1.03

Vascular dementia. J Neurol Sci (2012) 0.96

Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord (2009) 0.95

Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project. J Gerontol A Biol Sci Med Sci (2011) 0.93

Alerting, orienting, and executive attention in older adults. J Int Neuropsychol Soc (2010) 0.93

Cerebral blood flow in Alzheimer's disease. Vasc Health Risk Manag (2012) 0.91

Relationship between late-life hypertension, blood pressure, and Alzheimer's disease. Am J Alzheimers Dis Other Demen (2011) 0.91

Cognitive performance in hypotensive persons with spinal cord injury. Clin Auton Res (2009) 0.89

Homocysteine and mobility in older adults. J Am Geriatr Soc (2010) 0.88

Hypertension and cognitive function. Clin Geriatr Med (2009) 0.88

Optimal blood pressure for cognitive function: findings from an elderly African-American cohort study. J Am Geriatr Soc (2013) 0.87

Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87

Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly. Neurobiol Aging (2013) 0.86

Dementia in the oldest old. Nat Rev Neurol (2013) 0.86

A comparison of the predictive power of anthropometric indices for hypertension and hypotension risk. PLoS One (2014) 0.82

Phenomenon of declining blood pressure in elderly--high systolic levels are undervalued with Korotkoff method. BMC Geriatr (2011) 0.82

Hypertension, cognitive decline, and dementia: an epidemiological perspective. Dialogues Clin Neurosci (2007) 0.81

Impaired orthostatic blood pressure recovery and cognitive performance at two-year follow up in older adults: The Irish Longitudinal Study on Ageing. Clin Auton Res (2016) 0.80

Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden. BMC Cardiovasc Disord (2016) 0.78

Differing pattern of ambulatory blood pressure in very elderly men expresses dynamics in atherosclerotic load in the senescence. Int J Hypertens (2011) 0.78

Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM). BMC Public Health (2011) 0.78

Relation of Blood Pressure to Cognitive Impairment and Dementia. Curr Hypertens Rev (2007) 0.77

Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States. Psychol Aging (2016) 0.77

A warning index used in prescreening for Alzheimer's disease, based on self-reported cognitive deficits and vascular risk factors for dementia in elderly patients with type 2 diabetes. Int J Alzheimers Dis (2012) 0.77

Metaflammasome components in the human brain: a role in dementia with alzheimer's pathology? Brain Pathol (2016) 0.76

Low blood pressure and the risk of dementia in very old individuals. Neurology (2004) 0.75

Neurocardiovascular Instability and Cognition. Yale J Biol Med (2016) 0.75

Dissociation among hemodynamic measures in asymptomatic high grade carotid artery stenosis. J Neurol Sci (2016) 0.75

Postural Hypotension and Cognitive Function in Older Adults. Gerontol Geriatr Med (2017) 0.75

CADASIL: Treatment and Management Options. Curr Treat Options Neurol (2017) 0.75

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61

New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med (1983) 5.41

Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis (1975) 5.00

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA (1992) 4.77

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia (2010) 4.24

Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med (1982) 3.93

Screening for dementia with the memory impairment screen. Neurology (1999) 3.92

Clinical and prognostic subforms of new daily-persistent headache. Neurology (2010) 3.60

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia (2010) 3.54

Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med (1986) 3.43

Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32

Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology (1996) 3.15

Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06

Burden of migraine in the United States: disability and economic costs. Arch Intern Med (1999) 3.05

A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med (2000) 2.90

The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia (2003) 2.87

The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol (1988) 2.84

Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84

Prevalence of frequent headache in a population sample. Headache (2004) 2.82

Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain (2003) 2.79

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78

Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol (1985) (1986) 2.77

Epidemiology of tension-type headache. JAMA (1998) 2.63

Memory impairment on free and cued selective reminding predicts dementia. Neurology (2000) 2.58

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry (2010) 2.57

Leisure activities and the risk of amnestic mild cognitive impairment in the elderly. Neurology (2006) 2.51

Migraine and cardiovascular disease: a population-based study. Neurology (2010) 2.51

Migraine in adolescents: association with socioeconomic status and family history. Neurology (2007) 2.46

Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr (1976) 2.45

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology (2001) 2.43

Global prevalence of chronic migraine: a systematic review. Cephalalgia (2010) 2.43

Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain (2000) 2.41

The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35

Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia (2010) 2.35

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA (1985) 2.34

A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology (2005) 2.34

Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30

Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol (1999) 2.30

Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology (2001) 2.29

Hemicrania continua: ten new cases and a review of the literature. Neurology (1994) 2.26

Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann Intern Med (1978) 2.25

A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry (1988) 2.21

Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia (2010) 2.18

A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain (1997) 2.16

Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med (2000) 2.15

Memory and mental status correlates of modified Braak staging. Neurobiol Aging (2000) 2.15

Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology (2003) 2.14

Rapid detection of respiratory syncytial virus with a monoclonal antibody. J Clin Microbiol (1983) 2.13

Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13

Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr (1978) 2.01

Respiratory syncytial virus infections within families. N Engl J Med (1976) 1.99

Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis (1997) 1.98

Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics (1993) 1.97

Viral shedding patterns of children with influenza B infection. J Infect Dis (1979) 1.91

Headache and major depression: is the association specific to migraine? Neurology (2000) 1.91

An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology (1999) 1.89

Possible transmission by fomites of respiratory syncytial virus. J Infect Dis (1980) 1.87

Education delays accelerated decline on a memory test in persons who develop dementia. Neurology (2007) 1.87

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86

Nosocomial respiratory syncytial virus infections. N Engl J Med (1975) 1.85

Modes of transmission of respiratory syncytial virus. J Pediatr (1981) 1.84

Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia (2008) 1.83

Neonatal respiratory syncytial virus infection. N Engl J Med (1979) 1.82

Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia (1999) 1.82

Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81

Direct current shock and lidocaine in the treatment of digitalis-induced ventricular tachycardia. Am J Cardiol (1966) 1.81

Children with influenza A infection: treatment with rimantadine. Pediatrics (1987) 1.80

Variable adherence of fimbriated Haemophilus influenzae type b to human cells. Infect Immun (1985) 1.77

Is underimmunization a marker for insufficient utilization of preventive and primary care? Arch Pediatr Adolesc Med (1995) 1.77

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther (2000) 1.76

Immunization practices of pediatricians and family physicians in the United States. Pediatrics (1994) 1.75

Phase I clinical and pharmacokinetic study of taxol. Cancer Res (1987) 1.74

Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr (1985) 1.73

Cumulative lifetime migraine incidence in women and men. Cephalalgia (2008) 1.73

The effects of preclinical dementia on estimates of normal cognitive functioning in aging. J Gerontol B Psychol Sci Soc Sci (1996) 1.73

Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol (1993) 1.70

Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology (1999) 1.70

Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68

Rates, predictors, and consequences of remission from chronic migraine to episodic migraine. Neurology (2011) 1.67

Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology (2008) 1.66

Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology (2007) 1.64

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr (1990) 1.64

Pediatric migraine and the International Headache Society (IHS) criteria. Neurology (1997) 1.63

White matter abnormalities in mobility-impaired older persons. Neurology (2000) 1.61

Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr (1990) 1.60

Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache (1994) 1.59

A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology (1998) 1.57

Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology (2011) 1.57

Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen (1984) 1.56

Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia (2010) 1.56

Influenza surveillance in community-dwelling elderly compared with children. Arch Fam Med (1997) 1.55

A genotype of exceptional longevity is associated with preservation of cognitive function. Neurology (2006) 1.54

Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology (2001) 1.53

Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med (1981) 1.52